Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Microbiology and Infection"
DOI: 10.1016/j.cmi.2021.07.031
Abstract: Objectives The immunogenicity and safety of the Pfizer-BioNTech BNT162b2 mRNA vaccine in people living with HIV-1 (PLWH) are unknown. We thus aimed to assess the immunogenicity and safety of this vaccine in PLWH. Methods In… read more here.
Keywords: vaccine people; vaccine; immunogenicity safety; bnt162b2 mrna ... See more keywords